Phoenix, Arizona
United States
65
2026-03-26
6
2025-08-19
These are the the leading inventors for applications assigned to Creative Medical Technologies, Inc.:
Creative Medical Technologies, Inc. based in Phoenix, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
PREVENTION AND/OR TREATMENT OF TYPE 1 DIABETES BY AUGMENTATION OF MYELOID SUPPRESSOR CELL ACTIVITY
#2 | 2025-09-11PREVENTION OF DIABETES BY ENHANCEMENT OF IMMUNE MODULATION
#3 | 2025-09-11PREVENTION OF AUTOIMMUNE DIABETES
#4 | 2025-07-10Canine Universal Donor Mesenchymal Stem Cells
#5 | 2025-07-10Treatment of Disc Degeneration using B Regulatory Cells
#6 | 2025-06-19Artificial Intelligence Detection and Treatment of Biological, Chemical and Radiation Exposure
#7 | 2025-04-10Treatment of Lower Back Pain and Disc Degenerative Disease using Inducible Pluripotent Stem Cell Derived Mesenchymal Stem Cells and T Regulatory Cells Utility
#8 | 2025-03-06In Vitro and In Vivo Generation of Insulin Producing Cells
#9 | 2025-03-06Orthopedic Regeneration by Inducible Pluripotent Stem Cell Derived Mesenchymal Stem Cells
#10 | 2025-02-13Prevention of Immunological Rejection Using Mesenchymal Stem Cells and Derivatives Thereof
#11 | 2025-02-13Treatment of Spinal Cord Injury with T regulatory Cells
#12 | 2025-01-23Creation of Inducible Pluripotent Stem Cell Derived T Regulatory Cells by In Vitro Recapitulation ofThymic Development
#13 | 2025-01-02Enhanced Mobility of Inducible Pluripotent Stem Cell Derived T Regulatory Cells
#14 | 2024-11-14Induction of Antigen Specific Immunological Tolerance Using Inducible Pluripotent Stem Cell Derived Veto Cells
#15 | 2024-11-07Artificial Intelligence Enhanced Real Time Biological Optimization and Health Monitoring for Space Travel
#16 | 2024-10-24Three-Dimensional Printing of Organs, Organoids, and Chimeric Immuno-Evasive Organs
#17 | 2024-10-10Artificial Intelligence Guided Production of Cells and Organs from Pluripotent Stem Cells
#18 | 2024-10-03Artificial Intelligence Systems and Processes for In Silico Discovery of Immune Modulators and T Regulatory Cell Screening Methodologies
#19 | 2024-04-11TREATMENT OF DIABETES BY ENHANCEMENT OF PANCREATIC ISLET ENGRAFTMENT THROUGH REGENERATIVE IMMUNE MODULATION
#20 | 2024-02-08PREVENTION OF SPACE TRAVEL ASSOCIATED BONE DENSITY LOSS BY REGENERATIVE CELL POPULATIONS
#21 | 2024-02-08PROPHYLAXIS AND TREATMENT OF ORTHOPOX VIRUSES USING REGENERATIVE CELLS AND PRODUCTS THEREOF
#22 | 2024-02-08PREVENTION AND TREATMENT OF HAIR LOSS
#23 | 2024-02-08PREVENTION AND TREATMENT OF REPRODUCTIVE FAILURE BY REGENERATIVE CELLS AND ADJUVANTS
#24 | 2024-01-25POTENTIATION OF BONE MARROW CELL ACTIVITY BY COADMINISTRATION WITH OXYTOCIN
#25 | 2024-01-25TREATMENT OF LIMB ISCHEMIA BY BONE MARROW STEM CELLS AND MODIFICATION OF DISEASED MICROENVIRONMENT
#26 | 2024-01-18OVERCOMING TNF-ALPHA BLOCKADE RESISTANCE IN RHEUMATOID ARTHRITIS BY REGENERATIVE T REGULATORY CELL THERAPY
#27 | 2024-01-04REPAIR OF OVARIAN DAMAGE AND DAMPENING OF INFLAMMATORY MICROENVIRONMENT BY ADMINISTRATION OF MONOCYTIC-GRANULOCYTIC PROGENITORS WITH IMMUNE MODULATORY ACTIVITIES
#28 | 2023-12-21INDUCIBLE PLURIPOTENT STEM CELL DERIVED REGENERATIVE T CELLS
#29 | 2023-12-14GENERATION OF CONDITIONED MEDIA FROM INDUCIBLE PLURIPOTENT STEM CELL DERIVED ENDOTHELIAL PROGENITOR CELLS
#30 | 2023-12-14GENERATION OF CONDITIONED MEDIA FROM INDUCIBLE PLURIPOTENT STEM CELL DERIVED MESENCHYMAL STEM CELLS
#31 | 2023-12-07CELLULAR REGENERATIVE THERAPEUTICS FOR ENHANCEMENT/RESTORATION OF ENDOMETRIAL FUNCTION
#32 | 2023-12-07GENE THERAPEUTICS FOR ENHANCEMENT/RESTORATION OF ENDOMETRIAL FUNCTION
#33 | 2023-11-23DEGENERATING OVARIAN MICROENVIRONMENT RESISTANT MESENCHYMAL STEM CELLS
#34 | 2023-11-23CYTOKINE PRIMED REGENERATIVE CELLS FOR TREATMENT OF OVARIAN FAILURE
#35 | 2023-11-16EXOSOME BASED ASSAYS FOR DETERMINING CANDIDATES FOR OSTEOARTHRITIS STEM CELL THERAPY
#36 | 2023-11-16IMMUNOLOGICAL ENHANCEMENT OF STEM CELL ACTIVITY IN TREATMENT OF OVARIAN FAILURE
#37 | 2023-11-16STIMULATION OF OVARIAN FUNCTION SUBSEQUENT TO CHEMOTHERAPY AND/OR RADIATION THERAPY USING NATURAL KILLER CELLS
#38 | 2023-11-16PROTECTION FROM OVARIAN FAILURE BY LOW DOSE INTERLEUKIN-2 ADMINISTRATION
#39 | 2023-11-09CYTOKINE BASED ASSESSMENT OF RECIPIENT ABILITY TO RESPOND TO STEM CELL THERAPY FOR CARTILAGE REGENERATION
#40 | 2023-11-09PREVENTION OF MENOPAUSE ASSOCIATED OSTEOPOROSIS BY INTRA-OVARIAN ADMINISTRATION OF REGENERATIVE CELLS
#41 | 2023-10-19ENHANCEMENT OF STEM CELL THERAPY FOR CARTILAGE DEGENERATION BY ANTI-OXIDANT PRE-CONDITIONING
#42 | 2023-10-19ENHANCEMENT OF CARTILAGE REGENERATIVE ACTIVITY OF STEM CELL POPULATIONS BASED ON REDUCTION OF INTRA-ARTICULAR CELLULAR MATERIAL
#43 | 2023-10-19TREATMENT OF CARTILAGE DEGENERATION USING MYELOID SUPPRESSOR CELLS AND EXOSOMES DERIVED THEREOF
#44 | 2023-09-28SUPPRESSION OF DIABETES USING EXOSOMES FROM STEM CELL PROGRAMMED MYELOID CELLS
#45 | 2023-09-21THERAPEUTIC REGENERATIVE CELLS
#46 | 2023-08-24METHODS FOR QUANTIFYING POTENCY OF REGENERATIVE IMMUNOTHERAPIES
#47 | 2023-07-27REGENERATIVE CELL THERAPY FOR VIRAL INDUCED SEXUAL DYSFUNCTION
#48 | 2023-07-13REGENERATIVE CAR-T CELLS
#49 | 2023-07-13CHIMERIC ANTIGEN RECEPTOR REGENERATIVE GAMMA DELTA T CELLS
#50 | 2023-04-27REGENERATIVE T REGULATORY CELLS
#51 | 2023-01-19Therapeutic Monocytic Lineage Cells
#52 | 2022-12-08 ✅ Patent 12,391,925 granted on 2025-08-19PREVENTION AND/OR TREATMENT OF TYPE 1 DIABETES BY AUGMENTATION OF MYELOID SUPPRESSOR CELL ACTIVITY
#53 | 2022-07-28TREATMENT OF KIDNEY FAILURE USING EX VIVO REPROGRAMMED IMMUNE CELLS
#54 | 2022-07-21TREATMENT OF DIABETES USING IMMUNE CELLS REPROGRAMMED EX VIVO BY REGENERATIVE CELLS
#55 | 2022-06-30TREATMENT OF LIVER FAILURE BY EX VIVO REPROGRAMMED IMMUNE CELLS
#56 | 2022-06-30 ✅ Patent 12,385,011 granted on 2025-08-12TREATMENT OF HEART FAILURE AND/OR POST INFARCT PATHOLOGICAL REMODELING BY EX VIVO REPROGRAMMED IMMUNE CELLS
#57 | 2022-06-09INDUCTION OF INFECTIOUS TOLERANCE BY EX VIVO REPROGRAMMED IMMUNE CELLS
#58 | 2020-08-27EXTRACORPOREAL SHOCK WAVE ULTRASOUND FOR ENHANCEMENT OF REGENERATIVE ACTIVITIES IN ERECTILE DYSFUNCTION
#59 | 2018-12-20 ✅ Patent 10,842,815 granted on 2020-11-24Perispinal perfusion by administration of T regulatory cells alone or in combination with angiogenic cell therapies
#60 | 2018-12-06ENHANCEMENT OF NUCLEUS PULPOSUS REGENERATION BY ENHANCED PERFUSION OF PERISPINAL AREA BY COMBINATION DRUG, GENE AND CELLULAR THERAPIES
#61 | 2018-11-29 ✅ Patent 11,795,433 granted on 2023-10-24Generation of autologous immune modulatory cells for treatment of neurological conditions
#62 | 2018-11-22REGENERATION OF CORPUS CAVERNOSAL TISSUE
#63 | 2018-03-29TREATMENT OF STROKE BY AMNIOTIC FLUID DERIVED STEM CELL CONDITIONED MEDIA AND PRODUCTS DERIVED THEREOF
#64 | 2018-03-15 ✅ Patent 12,642,818 granted on 2026-06-02INDUCING AND ACCELERATING POST-STROKE RECOVERY BY ADMINISTRATION OF AMNIOTIC FLUID DERIVED STEM CELLS
#65 | 2018-01-18 ✅ Patent 10,792,310 granted on 2020-10-06Methods for treatment of premature ovarian failure and ovarian aging using regenerative cells
Also check out Creative Medical Technologies, Inc.'s (Phoenix, United States) applicant profile with 25 patent applications submitted.
131166 ⎘